Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX: Erratum

JCR Journal of Clinical Rheumatology 2026

View at publisher
Authors: Vijaya Rivera Terán, Iris Jazmín Colunga-Pedraza, David Vega‐Morales, Javier Merayo‐Chalico, Angel Alejandro Castillo Ortiz, Luis Francisco Valdés Corona, Fedra Consuelo Irazoque-Palazuelos, Julio Casasola-Vargas, Daniel Xavier Xibille-Friedmann, Sandra Miriam Carrillo-Vázquez, Guillermo Arturo Guaracha-Basáñez, Estefanía Torres-Valdez
+4 more Yatzil Reyna-Juárez, Beatriz Alcalá‐Carmona, Jiram José Torres-Ruiz, César Pacheco‐Tena
DOI: 10.1097/rhu.0000000000002315
Cited by: 0
References: 1

Abstract

In the December 2025 issue of Journal of Clinical Rheumatology, the article titled “Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX” needs to include a statement in the “Acknowledgements” section as the last line. The corrected section should read as follows:

Fields of Study & Subjects

Rheumatoid Arthritis Research and Therapies Autoimmune and Inflammatory Disorders Research Systemic Sclerosis and Related Diseases

Publication details

Journal / source
JCR Journal of Clinical Rheumatology
Volume
32
Issue
2
Pages
e54–e54
Publication date
23 February 2026
Language
EN